Elanco Animal Health (ELAN) Net Margin (2017 - 2026)
Elanco Animal Health (ELAN) posted Net Margin of 4.16% for Q1 2026, up 117.23% sequentially from 24.13% in Q4 2025, and down 146.0% YoY from 9.04% in Q1 2025.
Elanco Animal Health (ELAN) Net Margin (2017 - 2026) Analysis & Trends
Elanco Animal Health has reported Net Margin for 10 years, with the latest figure at 4.16% in Q1 2026.
- Quarterly Net Margin fell 146.0% year-over-year to 4.16% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 4.95% (down 1337.0% YoY) and the FY2025 annual result came in at 4.92%, down 1253.0% from the prior year.
- Net Margin grew to 4.16% in Q1 2026 per ELAN's latest filing, from 24.13% in the prior quarter.
- Over five years, Net Margin peaked at 35.34% in Q3 2024 and troughed at 102.62% in Q3 2023.
- A 5-year average of 6.42% and a median of 0.85% in 2022 frame the typical range for Net Margin.
- The sharpest annual moves came in 2023 and 2024: Net Margin plunged 9629 bps in 2023, then jumped 13796 bps in 2024.
- Over 5 years, Net Margin stood at 5.48% in 2022, then plunged by 148 bps to 13.62% in 2023, then jumped by 94 bps to 0.78% in 2024, then sank by 2976 bps to 24.13% in 2025, then jumped by 117 bps to 4.16% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 4.16%, 24.13%, and 2.99% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | -13.91% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 9.28% |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 42.51% |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | -3.16% |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 15.06% |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 3.95% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 0.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.95% |
| Mar 31, 2026 | 4.16% |
| Dec 31, 2025 | -24.13% |
| Sep 30, 2025 | -2.99% |
| Jun 30, 2025 | 0.89% |
| Mar 31, 2025 | 5.62% |
| Dec 31, 2024 | -0.78% |
| Sep 30, 2024 | 35.34% |
| Jun 30, 2024 | -4.22% |
| Mar 31, 2024 | 2.66% |
| Dec 31, 2023 | -13.62% |
| Sep 30, 2023 | -102.62% |
| Jun 30, 2023 | -9.18% |
| Mar 31, 2023 | 8.19% |
| Dec 31, 2022 | -5.48% |
| Sep 30, 2022 | -6.34% |
| Jun 30, 2022 | -0.85% |
| Mar 31, 2022 | 4.16% |
| Dec 31, 2021 | -9.44% |
| Sep 30, 2021 | -9.55% |